Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

13.09
Delayed Data
As of Apr 17
 -0.205 / -1.54%
Today’s Change
4.13
Today|||52-Week Range
13.42
+15.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.4B

Company Description

Merrimack Pharmaceuticals, Inc. engages in discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. It applies a systems biology-based approach to biomedical research, throughout the research and development process. Merrimack Pharmaceuticals was founded by Anthony J. Sinskey, Gavin MacBeath and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

Contact Information

Merrimack Pharmaceuticals, Inc.
One Kendall Square
Cambridge Massachusetts 02139
P:(617) 441-1000
Investor Relations:
(617) 441-7602

Employees

Shareholders

Individual stakeholders8.57%
Mutual fund holders36.87%
Other institutional18.25%

Top Executives

Robert J. MulroyPresident, Chief Executive Officer & Director
William M. McClementsHead-Corporate Operations
William A. SullivanChief Financial Officer & Treasurer
Eliel BayeverVice President & Medical Director-MM-398
Gavin MacBeathVice President-Translational Research

To view my watchlist

Not a member yet?

Sign up now for a free account